Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business
Ruma Paul

Bangladesh seeks to double vaccine purchases from Serum Institute of India

FILE PHOTO: The AstraZeneca COVID-19 vaccine manufactured by Serum Institute of India, is displayed to the media in Kathmandu, Nepal, January 21, 2021. REUTERS/Navesh Chitrakar

Bangladesh wants to buy up to 40 million more doses of the AstraZeneca coronavirus vaccine from the Serum Institute of India (SII), its health secretary said on Thursday, potentially more than doubling its purchases.

Bangladesh, a country of more than 160 million people, has already received vaccines from SII as part of an earlier deal for 30 million doses. India's government has also gifted the neighbour 2 million doses of the shot that SII, the world's biggest vaccine maker, is producing for many countries.

"Talks ongoing. Let's see," Health Secretary Abdul Mannan told Reuters.

SII did not respond to a request for comment.

Bangladesh is also due to get a total of 68 million doses of vaccines from a WHO-backed alliance, with the first shipment of around 10 million doses expected by June, Mannan said.

Currently, Beximco Pharmaceuticals Ltd is the sole distributor of the AstraZeneca vaccine in Bangladesh but the government has not yet decided who will handle future purchases from SII, Mannan said. "We have not ordered for any additional doses. As of now our total order is for 30 million doses," Beximco Pharmaceuticals' Chief Operating Officer Rabbur Reza told Reuters. "Additional orders will depend on the government."

(Reporting by Ruma Paul; additional reporting by Krishna N. Das; Editing by Bernadette Baum)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.